# Stellar Bio Systems, Inc.

- Location (FDA's records): Columbia, MD
- FDA decisions: 7 (1988–1999): 7 510(k) clearances
- Product codes: GQH (1), GQL (1), DHN (1), LKI (1), JRY (1), LSE (1), KTL (1)
- Predicates its devices cite: 0 (0 its own); citations of its devices by later devices: 0 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Recent decisions
- K992587: Epstein-Barr Virus Early Antigen (Ebv-EA) Igg Ifa Test System (Dec 22, 1999)
- K990915: Indirect Fluorescence Assay for Anti-Nuclear Antibodies Igg Antibody (Apr 21, 1999)
- K990916: Indirect Fluorescence Assay for Anti-Native Dna Igg Antibody (Apr 21, 1999)
- K914953: Ifa for Chlamydia Trachomatis Igg Antibody (Feb 19, 1992)
- K905608: Indirect Fluorescent Assay for Herpes Simplex 1 (Nov 7, 1991)
- K900974: Indirect Fluorescent Assay for (Ebv-Vca) Igg Anti. (Apr 16, 1990)
- K882835: Indirect Fluorescent Assay for (HCMV) (Dec 5, 1988)

Source page: https://510kreport.com/company/stellar-bio-systems